TNXP Earnings

Quarterly EPS
$-22.68
Q3 2024
$-9.83
Q4 2024
$-2.84
Q1 2025
$-3.86
Q2 2025
$-3.59
Q3 2025
$-3.95
Q4 2025
$-2.93
Q1 2026
$-2.44
Q2 2026
Latest Revenue13.5M
Latest Net Income-40552000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.4413.5M-40552000+577.9%+36.8%
Q1 2026-$2.936.9M-40194000+183.2%-3.2%
Q4 2025-$3.955.4M-46910000+108.8%+59.8%
Q3 2025-$3.593.3M-32010000+16.6%+84.2%
Q2 2025-$3.862.0M-28272000-9.5%+99.8%
Q1 2025-$2.842.4M-16829000-2.1%+99.5%
Q4 2024-$9.832.6M-22108000-31.7%+99.4%
Q3 2024-$22.682.8M-14213000-29.3%+99.4%
Q2 2024-$1,920.852.2M-78776000
Q1 2024-$535.722.5M-14939000
Q4 2023-$1,545.023.8M-27322000
Q3 2023-$3,863.004.0M-27975000
Tonix Pharmaceuticals (TNXP) — Earnings